grid-line

plasmic

Clinical tool used to predict severe ADAMTS13 deficiency in patients, often associated with thrombotic thrombocytopenic purpura (TTP). The PLASMIC score helps healthcare providers quickly assess the likelihood of severe ADAMTS13 deficiency, aiding in the timely diagnosis and treatment of TTP. This tool is primarily used by medical professionals, particularly hematologists and emergency physicians, to improve patient outcomes in critical care settings.
9.9K
Volume
+119%
Growth
regular